About Swiss Parenterals
Swiss Parenterals is a Healthcare company based in Ahmedabad (India) founded in 1986 by Vikrambhai Rasiklal Shah, and was acquired by ERIs Life Sciences in February 2024. Contract development and manufacturing for pharmaceutical products are offered. It operates on a Direct-to-Consumer (D2C) and Reseller / Distribution model. Its chief executive, as recorded, is Piyush Pandya. Swiss Parenterals offers products and services including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products. Its focus areas include Pharmaceuticals and Generic Drugs. Its competitors include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed competitors have raised funding.
Company details
Swiss Parenterals is involved in the development and manufacturing of sterile injectables, oral solids, semi-solids, and nutritional supplements for global markets. The company operates in over 80 countries, focusing on generic and specialty pharmaceuticals. Its services include product development, analytical support, and regulatory assistance at cGMP-compliant facilities. Approvals from EU-GMP, Brazilian ANVISA, and other international bodies are held by the company. A wide range of dosage forms, including complex formulations, are produced across three manufacturing units in Ahmedabad, India. Veterinary and Ayurvedic products are also offered to cater to diverse health needs.
- Headquarters Ahmedabad, India
- Founders Vikrambhai Rasiklal Shah
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website swiss.in
- Social LinkedIn
- Acquired by ERIs Life Sciences (Feb 2024)
- Legal Name Swiss Parenterals
- Annual Revenue$38.52 M (USD)36as on Mar 31, 2024
- Net Profit$8.45 M (USD)18as on Mar 31, 2024
- EBITDA$12.87 M (USD)20as on Mar 31, 2024
- Investors
- Acquired byERIs Life Sciences
(Feb 2024)
Associated legal entities of Swiss Parenterals
Swiss Parenterals is associated with 5 registered companies on The Company Check. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Syncorp Ventures Llp CIN AAW-0097 | Active | 23 Feb 2021 | Ahmedabad, Gujarat | 5 | View details | ||
| Swiss Exports Private Limited CIN U51100GJ1999PTC035242 | Converted To Llp | 01 Jan 1999 | Ahmedabad, Gujarat | ₹142 Cr | 56 | 2 | View details |
| Swiss Nutraceuticals Private Limited CIN U24239GJ2010PTC062207 | Active | 06 Sep 2010 | Ahmedabad, Gujarat | ₹0.0 Cr | 2 | View details | |
| Swiss Bio-Pharma Private Limited CIN U24230GJ2010PTC062185 | Active | 01 Sep 2010 | Ahmedabad, Gujarat | ₹0.0 Cr | 2 | View details | |
| Swiss Parenterals Limited CIN U85110GJ1997PLC031645 | Active | 04 Feb 1997 | Ahmedabad, Gujarat | ₹232 Cr | 411 | 5 | View details |
Products & Services of Swiss Parenterals
Swiss Parenterals offers a comprehensive portfolio of products and services, including Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products.
Sterile injectables are manufactured for global market distribution.
Oral solids are produced for various health condition treatments.
Semi-solids are optimized for controlled injection in treatments.
Nutritional supplements are offered to boost immunity and energy.
Ayurvedic products are developed for physical and mental health.
Investors in Swiss Parenterals
Swiss Parenterals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include ERIs Life Sciences.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmaceutical formulations for chronic diseases are manufactured and studied. | 2007 | eris.co.in | Ahmedabad, India |
Investor details for Swiss Parenterals
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Swiss Parenterals
The boards of the 5 registered companies of Swiss Parenterals currently have 8 directors; the longest-serving is Vikrambhai Rasiklal Shah, appointed in 2021. 19 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vikrambhai Rasiklal Shah DIN 00400395 | Designated Partner | 23 Feb 2021 | 5 yrs 8 mo | Syncorp Ventures Llp, Swiss Bio-Pharma Private Limited, Swiss Nutraceuticals Private Limited, Swiss Exports Private Limited |
| Naishadh Vikrambhai Shah DIN 01609076 | Designated Partner | 23 Feb 2021 | 5 yrs 8 mo | Syncorp Ventures Llp, Swiss Bio-Pharma Private Limited, Swiss Nutraceuticals Private Limited, Swiss Exports Private Limited, Swiss Parenterals Limited |
| Amiben Vikrambhai Shah DIN 02367294 | Designated Partner | 23 Feb 2021 | 5 yrs 8 mo | Syncorp Ventures Llp |
| Ruchira Naishadh Shah DIN 07695799 | Designated Partner | 23 Feb 2021 | 5 yrs 8 mo | Syncorp Ventures Llp |
| Shachi Vikram Shah DIN 08155999 | Designated Partner | 23 Feb 2021 | 5 yrs 8 mo | Syncorp Ventures Llp |
| Krishnakumar Vaidyanathan DIN 08976508 | Director | 15 Feb 2024 | 2 yrs 8 mo | Swiss Parenterals Limited |
| Kaushal Kamlesh Shah DIN 01229038 | Director | 15 Feb 2024 | 2 yrs 8 mo | Swiss Parenterals Limited |
| Sachin Shah DIN 06688639 | Director | 15 Feb 2024 | 2 yrs 8 mo | Swiss Parenterals Limited |
People of Swiss Parenterals
14 people are tracked at Swiss Parenterals (8 in leadership, 6 in team).
| Name | Role | Group |
|---|---|---|
| Founder & MD | Leadership | |
Piyush Pandya | CEO | Leadership |
| Director | Leadership | |
Rajesh Patel | Head Of Quality Assurance | Leadership |
| Director | Leadership | |
Sindhu Nair | Executive Director | Leadership |
| Chairman And Managing Director | Leadership | |
Dr. Swati Nagar | General Manager- Swiss Parenterals Ltd And Eris Lifesciences | Leadership |
Alpesh Rathod | Human Resources Executive | Team |
Jagat Shah | Purchase Manager | Team |
Prerak Barot | Senior Executive - Business Development | Team |
Mahesh Makwana | Human Resources Officer | Team |
Sindhu Marar | International Buisness | Team |
Bipin Goswami | Manager | Team |
Complete people profiles for Swiss Parenterals
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Swiss Parenterals
Figures of Swiss Bio-Pharma Private Limited, the primary company behind Swiss Parenterals, for FY 2024. Revenue was ₹1.9 Lakh. Net profit was ₹1.7 Lakh (89% margin). EBITDA was ₹1.7 Lakh (89% margin). Revenue has grown at a compounded annual rate of +144% over three years.
- ₹1.9 LakhRevenue · FY 2024
- ₹1.7 LakhNet profit · 89% margin
- ₹1.7 LakhEBITDA · 89% margin
- ₹1 LakhPaid-up capital
- +144%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Swiss Bio-Pharma Private Limited are on its company page.
Detailed financial statements for Swiss Parenterals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Swiss Parenterals
2 dated milestones of Swiss Parenterals across 38 years, from founding to its latest funding, stage changes and deals.
- Founded Swiss Parenterals is founded.
- Exit Acquired by ERIs Life Sciences.
Competitors of Swiss Parenterals
Swiss Parenterals has 3 listed competitors in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| akums.in | 2004 | Delhi, India | $70M | 395 | CDMO focusing on spectrum of dosage forms and therapeutic segments | |
| jubl.com | 1978 | Noida, India | Company offering a suite of R&D and manufacturing services for small molecules and generics | |||
| neclife.com | 1995 | Chandigarh, India | $46.85M | 175 | Cephalosporin APIs and generic formulations are manufactured. |
Detailed competitors of Swiss Parenterals
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Swiss Parenterals
The website of Swiss Parenterals (swiss.in) receives about 2.9K visits a month.
- Monthly visits2.9K
▲ 80.3% vs previous month
Websites whose visitors overlap most with Swiss Parenterals. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
qvo6.com | qvo6.com | 100% | #3,160,056 | – | |
| simandharherbal.com | 75% | #9,632,173 | View details |
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Swiss Parenterals (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 2,062 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 548 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 557 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Swiss Parenterals
Complete news archive for Swiss Parenterals
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Swiss Parenterals
Swiss Parenterals was founded in 1986.
Swiss Parenterals is headquartered in Ahmedabad, India. It is registered at Ahmedabad, Gujarat, India.
Piyush Pandya is the CEO of Swiss Parenterals, as recorded in our data.
Annual revenue of Swiss Parenterals is $38.52M as on Mar 31, 2024.
Swiss Parenterals is involved in the development and manufacturing of sterile injectables, oral solids, semi-solids, and nutritional supplements for global markets. The company operates in over 80 countries, focusing on generic and specialty pharmaceuticals. Its services include product development, analytical support, and regulatory assistance at cGMP-compliant facilities. Approvals from EU-GMP, Brazilian ANVISA, and other international bodies are held by the company. A wide range of dosage forms, including complex formulations, are produced across three manufacturing units in Ahmedabad, India. Veterinary and Ayurvedic products are also offered to cater to diverse health needs.
Swiss Parenterals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.
Swiss Parenterals offers Sterile Injectables, Oral Solids, Semi-Solids, Nutritional Supplements, and Ayurvedic Products.
Swiss Parenterals has 1 investor. Key investors include ERIs Life Sciences.
Swiss Parenterals is associated with 5 legal entities: Syncorp Ventures Llp, Swiss Bio-Pharma Private Limited, Swiss Nutraceuticals Private Limited and others.
Yes. Swiss Parenterals was acquired by ERIs Life Sciences in February 2024.
The legal entities of Swiss Parenterals currently have 9 directors, including Vikrambhai Rasiklal Shah, Naishadh Vikrambhai Shah, Amiben Vikrambhai Shah and others.